The Cigna Group CI Downgraded to Hold at Deutsche Bank Amid MultiYear Uncertainty Arm Holdings Faces US Antitrust Probe Over Chip Licensing Practices Bloomberg Reports Hormel Foods HRL Draws Analyst Attention Amid High Dividend Yield and Retail Margin Challenges HighFlying Stocks Resist Splits Which May Be Next to Crack Treasury Yield Surge Challenges RiskFree Notion Sparks Shift to Intermediate BBB and HighYield Bonds SpaceX Scrubs Starship Test Flight Hours After Releasing IPO Prospectus Retry Scheduled for Friday IPW Q3 2025 Earnings Narrow Loss Misses Estimates Stock Rises on Resilience PAVmed Q1 2026 Earnings WiderthanExpected Loss as Revenue Remains Absent Immunome Inc IMNM Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline Amid Pipeline Progress MBINN Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Lower MarineMax Inc HZO Q1 2026 Earnings EPS Falls Short of Expectations Amid Challenging Environment Progressive Corporation PGR Edges Lower Amid Sector Rotation Holds Near Key Support Northwest Bancshares NWBI Holds Steady at 1397 as Traders Eye Key Support and Resistance Futu Holdings FUTU Slumps 275 as Key Support Levels Come Into Focus Titan Acquisition Corp Warrants TACHW Edge Higher Support Holds as Price Approaches Key Resistance cbdMD Inc YCBD Slightly Lower as Stock Hovers Near Key Support at 071 BP Shares Slide After Board Ousts Chairman in Surprise Move HAFN Q4 2025 Earnings EPS Misses Estimates as Shares Slide 34 Smart Logistics Global Limited SLGB Surges 838 Whats Driving the Move Lloyds Banking Groups Potential PhaseOut of Halifax Brand Sparks Concern in Yorkshire Town Novak Djokovic Expresses Confidence in Pursuit of 25th Grand Slam Title at Roland Garros Oura Ring Maker Targets Over 9 Billion Valuation in Planned US IPO Freedom Broker Upgrades Realty Income O to Buy Following Strong Q1 AFFO Performance Coherent Corp Reports Q3 Fiscal 2026 Results Market Awaits Details on Revenue and Earnings Endurance Technologies IPO Opens Key Details and Market Implications Tony Blairs Economic Blueprint Diagnosis on Point Prescription Under Fire